1,360 filings
8-K
TEVA
Teva- Pharmaceutical Industries Ltd.
18 Apr 24
Regulation FD Disclosure
4:06pm
8-K
TEVA
Teva- Pharmaceutical Industries Ltd.
31 Jan 24
Results of Operations and Financial Condition
7:00am
8-K
TEVA
Teva- Pharmaceutical Industries Ltd.
8 Nov 23
2023 revenues outlook revised to $15.1 - $15.5 billion from $15.0 - $15.4 billion
7:01am
8-K
TEVA
Teva- Pharmaceutical Industries Ltd.
4 Oct 23
Sanofi and Teva announce exclusive collaboration to deliver inflammatory bowel disease treatment
6:05am
8-K
TEVA
Teva- Pharmaceutical Industries Ltd.
28 Sep 23
Teva Announces Changes to Executive Management Team
4:05pm
8-K
h6r821zogrblph2tj
24 Aug 23
Entry into a Material Definitive Agreement
7:30am
8-K
iugqs00
2 Aug 23
Departure of Directors or Certain Officers
4:16pm
8-K
8tya5y
2 Aug 23
Results of Operations and Financial Condition
7:00am
8-K
wa23gpdl1ode du81ieg
15 Jun 23
Submission of Matters to a Vote of Security Holders
4:01pm
8-K
znspnydm
8 Jun 23
Teva Concludes Nationwide Opioids Settlement Agreement
8:30am
8-K
vcrmkg3zn yxt9
11 May 23
Departure of Directors or Certain Officers
4:00pm
8-K
l1uwkdoq2ftx xc0iq
10 May 23
Results of Operations and Financial Condition
7:01am
8-K
hz238ei93kifg6 ea7
9 Mar 23
Entry into a Material Definitive Agreement
5:17pm
8-K
h33a1y9vep a1r
3 Mar 23
Regulation FD Disclosure
7:04am
8-K
zujep7
8 Feb 23
Results of Operations and Financial Condition
7:01am
8-K
dwd4fs
21 Nov 22
Teva Announces Appointment of Richard Francis as President and CEO
7:00am
8-K
bbi45cf0
3 Nov 22
Key financial highlights and outlook
7:00am
8-K
rfwu8h mel2pfcn32p0
26 Jul 22
Key financial highlights and outlook
4:56pm
8-K
zlna 30wk
23 Jun 22
Amendments to Articles of Incorporation or Bylaws
4:02pm
8-K
xbad03bx
3 May 22
Results of Operations and Financial Condition
7:01am